BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22862159)

  • 1. An analysis of the survival rate after radiotherapy in lung cancer patients with bone metastasis: is there an optimal subgroup to be treated with high-dose radiation therapy?
    Komatsu T; Kunieda E; Oizumi Y; Tamai Y; Akiba T
    Neoplasma; 2012; 59(6):650-7. PubMed ID: 22862159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic analysis of stereotactic radiotherapy for 39 patients with lung metastasis].
    Wu SX; Deng ML; Bao Y; Wang HY; Gao YH; Li FY; Huang SM
    Ai Zheng; 2006 Jul; 25(7):880-4. PubMed ID: 16831282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiation therapy for bone metastasis from hepatocellular carcinoma].
    Koom WS; Seong JS; Lee MJ; Park HC; Han KH; Chon JY; Moon YM; Suh CO
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):304-11. PubMed ID: 12499788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy for osseous metastases from hepatocellular carcinoma: a retrospective study of 57 patients.
    Kaizu T; Karasawa K; Tanaka Y; Matuda T; Kurosaki H; Tanaka S; Kumazaki T
    Am J Gastroenterol; 1998 Nov; 93(11):2167-71. PubMed ID: 9820391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers.
    Mani S; Todd MB; Katz K; Poo WJ
    J Urol; 1995 Jul; 154(1):35-40. PubMed ID: 7539867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of high-dose radiation therapy for isolated osseous metastasis in breast cancer in terms of oligo-recurrence.
    Niibe Y; Kuranami M; Matsunaga K; Takaya M; Kakita S; Hara T; Sekiguchi K; Watanabe M; Hayakawa K
    Anticancer Res; 2008; 28(6B):3929-31. PubMed ID: 19192651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis.
    Bae HM; Lee SH; Kim TM; Kim DW; Yang SC; Wu HG; Kim YW; Heo DS
    Lung Cancer; 2012 Sep; 77(3):572-7. PubMed ID: 22672969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: results on survival in the Dutch Bone Metastasis Study.
    van der Linden YM; Steenland E; van Houwelingen HC; Post WJ; Oei B; Marijnen CA; Leer JW;
    Radiother Oncol; 2006 Mar; 78(3):245-53. PubMed ID: 16545474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy for metastatic brain tumors from lung cancer--a review to devise individualized treatment plans.
    Itoh Y; Fuwa N; Morita K
    Nagoya J Med Sci; 2003 Nov; 66(3-4):119-28. PubMed ID: 14727688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reirradiation with local-field radiotherapy for painful bone metastases.
    Hayashi S; Hoshi H; Iida T
    Radiat Med; 2002; 20(5):231-6. PubMed ID: 12450102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.
    Quan AL; Barnett GH; Lee SY; Vogelbaum MA; Toms SA; Staugaitis SM; Prayson RA; Peereboom DM; Stevens GH; Cohen BH; Suh JH
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):695-703. PubMed ID: 15936158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a surgical resection for patients with stage IV non--small-cell lung cancer.
    Hanagiri T; Takenaka M; Oka S; Shigematsu Y; Nagata Y; Shimokawa H; Uramoto H; Tanaka F
    Clin Lung Cancer; 2012 May; 13(3):220-4. PubMed ID: 22138036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and clinical outcome of patients with lung adenocarcinoma with carcinomatous meningitis.
    Nakamura Y; Takahashi T; Tsuya A; Naito T; Kenmotsu H; Ono A; Shukuya T; Murakami H; Harada H; Watanabe R; Endo M; Mitsuya K; Nakajima T; Yamamoto N
    Anticancer Res; 2012 May; 32(5):1811-6. PubMed ID: 22593466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of radiotherapy in oseosarcoma.
    Schwarz R; Bruland O; Cassoni A; Schomberg P; Bielack S
    Cancer Treat Res; 2009; 152():147-64. PubMed ID: 20213389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic analysis of 151 patients with maxillary sinus malignant neoplasms].
    Guo GF; Yang AK; Xie RH; Chen ZH; Wu QL; Ou SM; Liu WW; Xia LP; Chen MY; Zhang JX; Wu JH
    Ai Zheng; 2004 Nov; 23(11 Suppl):1546-50. PubMed ID: 15566677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy for painful bone metastases from hepatocellular carcinoma.
    Seong J; Koom WS; Park HC
    Liver Int; 2005 Apr; 25(2):261-5. PubMed ID: 15780048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the prognostic significance of refinement and stratification of distant metastasis status in 1016 cases of nasopharyngeal carcinoma].
    Pan CC; Lu J; Chen P; Li X; Jin YD; Zhao M; Xia YF; Wu PH
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):595-9. PubMed ID: 24314217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.